期刊文献+

抗环瓜氨酸肽抗体联合类风湿因子IgA和IgM诊断类风湿关节炎的临床价值 被引量:5

Clinical value of anti-cyclic citrullinated peptide antibody combined with rheumatoid factor IgA and IgM for diagnosing rheumatoid arthritis
下载PDF
导出
摘要 目的评估单独或联合检测抗角蛋白抗体(AKA)、抗环瓜氨酸肽(CCP)抗体、类风湿因子(RF)IgA和IgM对类风湿关节炎(RA)的诊断价值。方法分别检测195例RA患者和195例对照者血清中的AKA、抗-CCP抗体、IgA-RF和IgM-RF,AKA采用间接免疫荧光的方法检测,抗-CCP抗体、IgA-RF和IgM-RF采用酶联免疫吸附试验检测,分析上述抗体在RA中的敏感性和特异性,比较抗-CCP抗体联合IgA-RF或(和)IgM-RF诊断RA的敏感性、特异性、阳性预测值和阴性预测值。结果抗-CCP抗体、IgA-RF和IgM-RF 3项联合检测特异性最高。抗-CCP抗体+IgA-RF的阳性预测值(87.59%)要明显高于抗-CCP抗体+IgM-RF(78.49%)。结论抗-CCP抗体与IgA/IgM-RF联合检测可以显著提高RA的诊断效能,降低误诊率。 Objective To evaluate the value of the single or combined detection of anti keratin antibody (AKA) ,anti-cyclic citrullinated peptide(CCP) antibody and rheumatoid factor(RF) for the diagnosis of rheumatoid arthritis(RA). Methods Serum AKA,anti CCP antibody,IgA-RF and IgM-RF were detected in 195 cases of RA and 195 controls. AKA was detected by using the indirect immunofluorescence method,RF and anti-CCP antibody were detected by using ELISA. The specificity and sensitivity of those antibodies in RA were analyzed in the diagnosis of RA. The sensitivity, specificity, positive predictive value(PPV) and negative predictive value(NPV) of anti-CCP anti- body combined IgA-RF and/or IgM-RF for diagnosing RA were compared. Results The combination detection of an- ti-CCP antibody, IgA-RF and IGM-RF had the highest specificity. The positive predictive value of anti-CCP antibody + IgA-RF was 87. 59%,which was significantly higher than 78.49% of anti CCP antibody+IGM-RF. Conclusion The combined detection of anti CCP antibody and IgA/IgM-RF can significantly improve the diagnostic efficiency and reduce the misdiagnosis rate.
出处 《检验医学与临床》 CAS 2014年第2期173-175,共3页 Laboratory Medicine and Clinic
关键词 类风湿因子IgA 类风湿因子IgM 抗环瓜氨酸肽抗体 类风湿关节炎 IgA-RF IgM-RF anti-cyclic citrullinated peptide antibody rheumatoid arthritis
  • 相关文献

参考文献15

  • 1Bukhari M, Harrison B,Lunt M,et al. Time to first occur rence of erosions in inflammatory polyarthritis: results from a prospective community based study[J]. ArthritisRheum,2001,44(6) : 1248-1253.
  • 2Posnett DN, Edinger J. When do microbes stimulate rheu- matoid factor[J]. J Exp Med,1997,185(10) :1721-1723.
  • 3顾昳丽,陈宇明,吕玲,徐麦玲,邹和建.抗环瓜氨酸肽抗体类风湿因子与类风湿关节炎活动度及骨侵蚀相关性的研究[J].中华风湿病学杂志,2005,9(11):681-683. 被引量:5
  • 4Vittecoq O, Pouplin S, Krzanowska K, et al. Rheumatoid factor is the strongest predictor of radiological progres- sion of rheumatoid arthritis in a three-year prospective study in community-recruited patients [J]. Rheumatology (Oxford) ,2003,42(8) :939-946.
  • 5Bukhari M,Lunt M, Harrison BJ ,et al. Rheumatoid factor is the major predictor of increasing severity of radiograph- ic erosions in rheumatoid arthritis:results from the Nor- folk Arthritis Register Study,a large inception cohort[J]. Arthritis Rheum, 2002,46 (4) : 906-912.
  • 6Knijff-Dutmer E, Drossaers-Bakker W, Verhoeven A, et al. Rheumatoid factor measured by fluoroimmunoassay: a responsive measure of rheumatoid arthritis disease activi- ty that is associated with joint damage[-J]. Ann Rheum Dis,2002,61(7) :603-607.
  • 7Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the clas- sification of rheumatoid arthritis [J]. Arthritis Rheum, 1988,31(3) :315-324.
  • 8Schellekens GA, Visser H, de Jong BA, et al. The diag- nostic of rheumatoid arthritis recognizing a cyclic citrulli- nated peptide[J]. Arthritis Rheum, 2000,43 ( 1 ) : 155-163.
  • 9Saraux A, Berthelot JM, Devauchelle V, et al. Value of an-tibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis[J]. J Rheumatol,2003,30(12): 2535-2539.
  • 10Rantap/igt-Dahlqvist S, de Jong BA, Berglin E, et al. Anti bodies against cyclic citrullinated peptide and IgA rheu- matoid factor predict the development of rheumatoid ar- thritis[J]. Arthritis Rheum,2003,48(10) :2741-2749.

二级参考文献19

  • 1李鸿斌,中华医学杂志,2000年,80卷,20页
  • 2李小峰,中华风湿病杂志,1999年,3卷,208页
  • 3Van de Putte LB, van Riel PL. Modified disease activity scores that includetwenty-eight-joint counts: development and validation in a prospective longitudinal studyof patients with rheumatoid arthritis. Arthritis Rheum, 1995, 38: 44-48.
  • 4Van der Heijde DM, van′t Hof MA, van Riel PL, et al. Judging disease activity inclinical practice in rheumatoid arthritis: first step in the development of a diseaseactivity score. Ann Rheum Dis, 1990, 49: 916-920.
  • 5Vittecoq O, Pouplin S, Krzanowska K, etal. Rheumatoid factor is the strongest predictor of radiological progression of rheumatoidarthritis in a three-year prospective study in community-recruited patients. Rheumatology(Oxford), 2003, 42: 939-946.
  • 6Bukhari M, Lunt M, Harrison BJ, et al. Rheumatoid factor is the major predictor ofincreasing severity of radiographic erosions in rheumatoid arthritis: results from theNorfolk Arthritis Register Study, a large inception cohort. Arthritis Rheum, 2002, 46:906-912.
  • 7Listing J, Rau R, Muller B, et al. HLA-DRB1 genes, rheumatoid factor, and elevatedC-reactive protein: independent risk factors of radiographic progression in earlyrheumatoid arthritis. J Rheumatol, 2000, 27: 2100-2109.
  • 8Kaltenhauser S, Wagner U, Schuster E, et al. Immunogenetic markers and seropositivitypredict radiological progression in early rheumatoid arthritis independent of diseaseactivity. J Rheumatol,2001, 28: 735-744.
  • 9Machold KP, Stamm TA, Eberl G J, et al. Very recent onset arthritis-clinical,laboratory, and radiological findings during the first year of disease. J Rheumatol, 2002,29: 2278-2287.
  • 10Knijff-Dutmer E, Drossaers-Bakker W, Verhoeven A, et al.Rheumatoid factor measured byfluoroimmunoassay: a responsive measure of rheumatoid arthritis disease activity that isassociated with joint damage. Ann Rheum Dis, 2002, 61: 603-607.

共引文献292

同被引文献54

  • 1何芳.汪佳利,尚华.联合检测抗CCP、AKA、RF在85例类风湿性关节炎中的临床意义[J].中国保健营养(中旬刊),2012,14(z2):18.
  • 2Manivelavan D, Vijayasamundeeswari CK. Anti-cyclic citrullinated peptide antibody: an early diagnostic and prognostic biomarker of rheumatoid arthritis [J]. J Clin Diagn Res,2012,6(8):1393-1396.
  • 3AletahaD, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology / European League against rheumatism collaborative initiative[ J]. Ann Rheum Dis,2010,69(2):1580-1588.
  • 4ScheHekens GA, de Jong BA, Vail den Hoogen FH, et al. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies [ J ]. J Clin Invest, 1998,101 ( 1 ) :273-281.
  • 5Neogi T,Aletaha D, Silman AJ, et al. The 2010 American college of Rheumatology/ European league against rheumatism classification criteria for rheumatoid arthritis : phase 2 methodological report [J]. Arthritis Rheum,2010,62(9) :2582-2591.
  • 6Gomez EL, Gun SC, Somanath SD, et al. Ethnic differences in the prognostic utility of rheumatoid factor isotypes and anticyclie citrullinated peptides in rheumatoid arthritis patients:a cross-sectional study [ J ]. Mod Rheumato1,2013,23 (4) :716-721.
  • 7Gibofsky A. Overview of epidemiology,pathophysiology, and diagnosis of rheumatoid arthritis[J]. Is J Manag Care, 2012.18 : 295-302.
  • 8Damjanovska L,Thabet MM, [Jevarth EW, et al. Diagnos- tic value of anti-MCV antibodies in differentiating early inflammatory arthritis[J]. Ann Rheum Dis, 2010,69 : 730- 732.
  • 9Da Mota LM,Santos-Neto LL,Pereira IA,et al. Auto an- tibodies in early rheumatoid arthritis:Brasilia cohort:Re- sults of a three year serial analysis[J]. Rev Bras Reuma- tol,2011,51:564-571.
  • 10赵金霞,王志敏,栗占国.以抗环瓜氨酸肽抗体改进对1987年美国风湿病学会关于类风湿关节炎分类标准的探讨[J].中华风湿病学杂志,2009,13(4):236-239. 被引量:33

引证文献5

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部